| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1From the Department of Anatomy 2, University of Erlangen-Nuremburg, Erlangen, Germany; and the 2Department of Mechanical and Industrial Engineering and the 3Department of Ophthalmology, University of Toronto, Toronto, Ontario, Canada.
PURPOSE. TGF-ß2 is known to be present at elevated levels in the aqueous humor of patients with primary open-angle glaucoma (POAG). Studies have shown that TGF-ß2 influences cultured trabecular meshwork (TM) cells, but the effects of this cytokine on intact TM and outflow facility have not been studied. The purpose of this study was to investigate whether TGF-ß2 treatment induces changes in outflow facility and morphologic changes in the TM tissue and whether these changes are comparable to those previously recorded in glaucomatous eyes.
METHODS. Baseline facility was measured in paired human eyes (n = 8 pairs), with a constant-flow anterior segment culture system. Medium perfusing experimental eyes was then supplemented with activated human recombinant TGF-ß2 (3.0 ng/mL, comparable to or slightly greater than measured aqueous humor levels in patients with POAG), and facility was measured for at least 8 days. At the conclusion of the perfusion, eyes were fixed and processed for light microscopy, transmission electron microscopy, and immunolabeling studies.
RESULTS. TGF-ß2 perfusion reduced outflow facility by 27% (P = 0.03) and promoted focal accumulation of fine fibrillar extracellular material in multilayered structures under the inner wall of Schlemm’s canal. In treated eyes, Schlemm’s canal was 27% shorter (P = 0.02), and the length of the inner wall apparently available for fluid flow was 33% less (P = 0.001), both compared with paired control eyes.
CONCLUSIONS. TGF-ß2 reduces outflow facility when perfused into cultured human anterior segments. Furthermore, TGF-ß2 affects the extracellular matrix of the trabecular meshwork in a manner that is consistent with the observed reduction in outflow facility. Although the distribution of accumulated fibrillar material was different in these perfused eyes than that in POAG, the difference could be due to variation in biomechanical environment for TM cells in cultured anterior segments compared with the living eye. Overall, these results support the hypothesis that elevated TGF-ß2 levels in the aqueous humor play a role in the pathogenesis of the ocular hypertension in POAG.
This article has been cited by other articles:
|
|
 |
|
  I. Michael, M. Shmoish, D. S. Walton, and S. Levenberg Interactions between Trabecular Meshwork Cells and Lens Epithelial Cells: A Possible Mechanism in Infantile Aphakic Glaucoma Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 3981 - 3987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kuchtey, M. E. Kallberg, K. N. Gelatt, T. Rinkoski, A. M. Komaromy, and R. W. Kuchtey Angiopoietin-like 7 Secretion Is Induced by Glaucoma Stimuli and Its Concentration Is Elevated in Glaucomatous Aqueous Humor Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3438 - 3448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schlunck, H. Han, T. Wecker, D. Kampik, T. Meyer-ter-Vehn, and F. Grehn Substrate Rigidity Modulates Cell Matrix Interactions and Protein Expression in Human Trabecular Meshwork Cells Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 262 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Zode, A. F. Clark, and R. J. Wordinger Activation of the BMP Canonical Signaling Pathway in Human Optic Nerve Head Tissue and Isolated Optic Nerve Head Astrocytes and Lamina Cribrosa Cells Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5058 - 5067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Wan, D. F. Woodward, C. L. Cornell, H. G. Fliri, J. L. Martos, S. N. Pettit, J. W. Wang, A. B. Kharlamb, L. A. Wheeler, M. E. Garst, et al. Bimatoprost, Prostamide Activity, and Conventional Drainage Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4107 - 4115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Xue, N. Comes, and T. Borras Presence of an Established Calcification Marker in Trabecular Meshwork Tissue of Glaucoma Donors Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3184 - 3194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Wordinger, D. L. Fleenor, P. E. Hellberg, I.-H. Pang, T. O. Tovar, G. S. Zode, J. A. Fuller, and A. F. Clark Effects of TGF-{beta}2, BMP-4, and Gremlin in the Trabecular Meshwork: Implications for Glaucoma Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1191 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Fuchshofer, A. H. L. Yu, U. Welge-Lussen, and E. R. Tamm Bone Morphogenetic Protein-7 Is an Antagonist of Transforming Growth Factor-{beta}2 in Human Trabecular Meshwork Cells Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 715 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Fautsch, D. H. Johnson, and the Second ARVO/Pfizer Research Institute Working Aqueous humor outflow: what do we know? Where will it lead us? Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4181 - 4187. [Full Text] [PDF]
|
|
|
|
|
|
B. Bachmann, M. Birke, D. Kook, M. Eichhorn, and E. Lutjen-Drecoll Ultrastructural and Biochemical Evaluation of the Porcine Anterior Chamber Perfusion Model Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 2011 - 2020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Fleenor, A. R. Shepard, P. E. Hellberg, N. Jacobson, I.-H. Pang, and A. F. Clark TGF{beta}2-Induced Changes in Human Trabecular Meshwork: Implications for Intraocular Pressure Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 226 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sugita, T. F. Ng, P. J. Lucas, R. E. Gress, and J. W. Streilein B7+ Iris Pigment Epithelium Induce CD8+ T Regulatory Cells; Both Suppress CTLA-4+ T Cells J. Immunol., January 1, 2006; 176(1): 118 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gottanka, A. Kuhlmann, M. Scholz, D. H. Johnson, and E. Lutjen-Drecoll Pathophysiologic Changes in the Optic Nerves of Eyes with Primary Open Angle and Pseudoexfoliation Glaucoma Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4170 - 4181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Fuchshofer, M. Birke, U. Welge-Lussen, D. Kook, and E. Lutjen-Drecoll Transforming Growth Factor-{beta}2 Modulated Extracellular Matrix Component Expression in Cultured Human Optic Nerve Head Astrocytes Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 568 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhao, K. E. Ramsey, D. A. Stephan, and P. Russell Gene and Protein Expression Changes in Human Trabecular Meshwork Cells Treated with Transforming Growth Factor-{beta} Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4023 - 4034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Ethier, S. Wada, D. Chan, and W. D. Stamer Experimental and Numerical Studies of Adenovirus Delivery to Outflow Tissues of Perfused Human Anterior Segments Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1863 - 1870. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
